|
ADHD News Articles from the adhd information library
Greetings!
Here is your weekly edition of your ADHD News Articles from the ADHD Information Library at http://newideas.net. Visit us for the latest news and insights on parenting and teaching those with ADHD.
|
Adderall XR, Shire Pharmaceuticals, and a Glimpse Into the Future
Barron's Magazine, is a financial weekly published by Dow Jones that
keeps a very close eye on the world's financial news and the
corporations that are making news. Recently they ran a short series of
articles on Shire Pharmaceuticals and the potential problems ahead for
the company.
The reason that these articles are of interest to parents of children
with ADHD, is that Shire makes Adderall, Adderall XR, and Vyvanse, all
major medications used for ADHD treatment. The problems for Shire may
be blessings for parents, so here are some of the details:
Shire has the patent on Adderall XR, which has been a controversial
medication in the treatment of ADHD for several years now. And Shire's
patent on the drug expires in April of 2009. This means that other
companies can begin selling "generic" versions of Adderall XR (which
will initially be manufactured by Shire) next spring, potentially at
prices far lower than Shire's prices for Adderall XR.
Barron's claims that Shire's Adderall XR is the most prescribed drug
for ADHD in the world with about 23% of the market, and that of Shire's
$2.4 billion in revenue last year, over 40% came from Adderall sales
(about $1 billion). As investors look into the near future, and respond
to what they see, Shire Pharmaceutical's stock has fallen over 40%
since September of 2007.
Vyvanse is Shire's newest ADHD medication, a true pro-drug, where the
medication's precursors are linked to amino acids to make the
medications less likely to be abused. At present Barron's reports that
Vyvanse has captured about 7.5% of the ADHD drug market, and that it is
not gaining in popularity as quickly as some had hoped.
| |
Mercury Poisoning, Heavy Metal or Chemical Toxicity, and Brain Development
Protect Your Child's Brain from Mercury and Other Heavy Metals and Environmental Chemicals
The dangers of lead poisoning and mercury toxicity have been known for centuries. And research over the past thirty years has shown that low-level exposures to heavy metals from paint, exhaust, and other environmental sources has toxic effects. These metals are neurotoxins and adversely impact brain development and performance.
Mercury exposure has been linked to lower intelligence scores and neurobehavioral problems in children of mothers exposed to contaminated seafood. We are convinced that dental amalgam fillings, which are over 40% mercury, plus toxic nickel, copper, and cadmium, also can cause neurological and immune system dysfunctions.
Two informative but shocking videos on the internet illustrate the points. The first video from the International Academy of Oral Medicine and Toxicity shows that amalgam fillings expose their "owners" to mercury vapor. The second video from the University of Calgary, Ontario, Canada, shows mercury ions destroying nerve cells. These are "must see" videos.
One in six children in the USA has a developmental disability or neuro-developmental disorder, such as ADHD, autism or Asperger's, PDD, etc. It is possible, in fact likely, that exposure to heavy metals and chemical toxins both in utero and in early childhood cause damage to the developing brain, resulting in various neurological disorders.
Continue reading this article...
This full article can be found at: http://newideas.net/adhd/differential-diagnosis/mercury-chemical-toxicity |
Essential Fatty Acids and ADHD
The studies on Essential Fatty Acid levels in Attention Deficit Disorder subjects vs. non- ADD ADHD subjects are interesting.
The ADD ADHD groups had significantly lower concentrations of key essential fatty acids than did the control groups, and about 40% of the ADD ADHD group showed these signs of EFA deficiency:
* increased thirst, * frequent urination, * dry skin, * dry or brittle hair.
Low levels of Omega 6 EFAs contributed to higher incidents of illness (colds, flu, etc.), and deficits in Omega 3 EFAs contributed to problems with learning, behavior, sleep, and temper.
Continue reading this article...
This full article can be found at: http://newideas.net/adhd/research/essential-fatty-acids
|
|
|
|
|
Try Attend!

ATTEND Clinical Trial Results
View the clinical trials results. See
why there are so many happy customers...(more)
Compare ATTEND to RITALIN and other stimulants used to reat ADHD In "head to head" competition:
Ritalin
vs ATTEND...(see who wins) 
72 ingredients in Attend
The ATTEND formula was carefully
developed by a
neuro-scientist, tested for effectiveness, and is
available today! Learn more about ATTEND here.
|
|